Core Cap Advisors, LLC Alterity Therapeutics LTD Transaction History

Core Cap Advisors, LLC

  • $2.07 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.3 - $4.9 $64 - $1,058
216 New
216 $0
Q2 2022

Aug 11, 2022
BUY
$0.01 - $0.02 $2 - $4
216 New
216 $0
Q1 2022

Apr 29, 2022
SELL
$0.01 - $0.02 $2 - $4
-216 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$0.01 - $0.02 $2 - $4
216 New
216 $1,000

Others Institutions Holding ATHE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ALTERITY THERAPEUTICS LTD

ATHE Quotes by TradingView
  • Ticker ATHE
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,114,600
  • Market Cap $149M
  • Description
  • Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...
More about ATHE
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email